HomeAYJ • FRA
add
Valneva SE
Nakaraang pagsara
€2.65
Sakop ng araw
€2.67 - €2.69
Sakop ng taon
€2.47 - €7.24
Market cap
444.24M EUR
Average na Volume
10.99K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 38.06M | -5.41% |
Gastos sa pagpapatakbo | 110.47M | 137.29% |
Net na kita | -24.93M | -47.37% |
Net profit margin | -65.51 | -55.79% |
Kita sa bawat share | -0.19 | 33.97% |
EBITDA | -107.68M | -406.60% |
Aktuwal na % ng binabayarang buwis | 0.66% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 131.41M | -35.71% |
Kabuuang asset | 466.57M | -14.01% |
Kabuuang sagutin | 300.29M | -14.66% |
Kabuuang equity | 166.28M | — |
Natitirang share | 131.55M | — |
Presyo para makapag-book | 2.10 | — |
Return on assets | -57.99% | — |
Return on capital | -72.36% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -24.93M | -47.37% |
Cash mula sa mga operasyon | -37.83M | 7.97% |
Cash mula sa pag-invest | 895.00K | 129.15% |
Cash mula sa financing | -9.13M | -61.34% |
Net change in cash | -45.23M | 9.68% |
Malayang cash flow | -80.38M | -70.10% |
Tungkol
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Itinatag
2013
Website
Mga Empleyado
700
